SOBR Safe (NASDAQ:SOBR) Stock Rating Upgraded by Wall Street Zen

SOBR Safe (NASDAQ:SOBR) was upgraded by equities research analysts at Wall Street Zen to a “sell” rating in a research note issued on Saturday.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of SOBR Safe in a research report on Wednesday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, SOBR Safe has an average rating of “Sell”.

SOBR Safe Stock Performance

NASDAQ:SOBR opened at $0.53 on Friday. SOBR Safe has a fifty-two week low of $0.35 and a fifty-two week high of $4.00. The company has a 50 day simple moving average of $0.88 and a two-hundred day simple moving average of $0.94. The company has a market capitalization of $1.49 million, a PE ratio of -0.09 and a beta of 1.23.

SOBR Safe (NASDAQ:SOBR) last issued its quarterly earnings results on Thursday, April 30th. The company reported ($0.82) earnings per share (EPS) for the quarter. SOBR Safe had a negative return on equity of 172.71% and a negative net margin of 2,166.28%.The firm had revenue of $0.08 million during the quarter.

Institutional Investors Weigh In On SOBR Safe

An institutional investor recently bought a new position in SOBR Safe stock. Citadel Advisors LLC purchased a new stake in SOBR Safe, Inc. (NASDAQ:SOBR) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 19,272 shares of the company’s stock, valued at approximately $67,000. Citadel Advisors LLC owned 1.27% of SOBR Safe as of its most recent filing with the Securities & Exchange Commission. 7.93% of the stock is owned by institutional investors and hedge funds.

SOBR Safe Company Profile

SOBR Safe, Inc (NASDAQ: SOBR) is a technology company specializing in the development and commercialization of cognitive impairment monitoring solutions. The company’s flagship offerings consist of handheld breath alcohol screening devices and integrated cognitive assessment tools designed to detect impairment in real time. SOBR Safe’s product line pairs portable breathalyzers with proprietary software that captures, records and analyzes impairment data to help organizations maintain safety and compliance standards.

Founded in 2020 and headquartered in Vancouver, Canada, SOBR Safe has focused on research and development of non-invasive impairment detection technology.